-
Foundation Medicine Integrates with Epic, Launch of Sickle Cell Disease Clin Trials Network, New Products
Clinical Research News | New video eConsent capabilities from Medidata, Kaia Health revamps C-Suite to expand clinical capabilities, clinical trial partnerships for Curebase, Adagene, and Telix Pharmaceuticals, and Clinerion expands global hospital network. Plus new products from Smart Meter, Digital Science, and Elsevier.
Sep 1, 2021
-
Biosafety Oversight: A Critical Component of Clinical Gene Transfer Research
Clinical Research News | The goal of biosafety in research is the management of risk to people and the environment associated with exposure to biological agents and toxins and to genetically modified vectors, DNA or RNA. There are two ways that biosafety oversight of clinical trials could be improved to become more consistent and transparent. First, federal rules governing which clinical trials require biosafety approval should be broadened and clarified. Second, the National Institutes of Health (NIH) could restore certain aspects of central risk assessment and guidance that were eliminated recently.
Aug 31, 2021
-
How Doctors And Patients Are Partnering To Evolve The Decentralized Clinical Trial Model
Clinical Research News | Decentralized clinical trials (DCTs), which leverage technology to collect patient data remotely, have recently begun to change the industry by helping to increase trial access and participant diversity. As DCTs continue to evolve, we have learned that technology can allow us to bring research into almost any clinical setting. In fact, patients can even identify trials, and bring their own physician on board to administer most of the necessary care to participate; a concept I like to call Bring Your Own Physician (BYOP).
Aug 26, 2021
-
Looking Closely at Cancer Clinical Trials and the Patient Experience
Clinical Research News | In a study published this month in JAMA Network Open, a team from the University of Pennsylvania School of Nursing worked with 20 patients with cancer that withdrew or were withdrawn from a cancer clinical trial to help clarify the post-trial needs of cancer patients participating in clinical trials and define what constitutes responsible transitions when patients exit trials.
Aug 25, 2021